BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11026699)

  • 1. Accelerated radiotherapy with concomitant ACNU/Ara-C for the treatment of malignant glioma.
    Anders K; Grabenbauer GG; Schuchardt U; Fahlbusch R; Fietkau R; Sauer R; Krauseneck P
    J Neurooncol; 2000 May; 48(1):63-73. PubMed ID: 11026699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
    Weller M; Müller B; Koch R; Bamberg M; Krauseneck P;
    J Clin Oncol; 2003 Sep; 21(17):3276-84. PubMed ID: 12947063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of chemotherapy with ACNU plus cisplatin followed by cranial irradiation in patients with newly diagnosed glioblastoma multiforme.
    Choi IS; Lee SH; Kim TY; Bang JS; Paek SH; Kim S; Kim IH; Heo DS; Bang YJ; Kim DG; Jung HW; Kim NK
    J Neurooncol; 2002 Nov; 60(2):171-6. PubMed ID: 12635665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
    BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
    Mizoe JE; Tsujii H; Hasegawa A; Yanagi T; Takagi R; Kamada T; Tsuji H; Takakura K;
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):390-6. PubMed ID: 17459607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of ACNU alone and combined with tegafur as additions to radiotherapy of the treatment of malignant gliomas--a cooperative clinical trial].
    Ushio Y; Abe H; Suzuki J; Tanaka R; Kitamura K; Miwa T; Matsutani M; Takeuchi K; Takakura K; Nomura K
    No To Shinkei; 1985 Oct; 37(10):999-1006. PubMed ID: 3000412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperfractionated radiotherapy and multi-agent chemotherapy (procarbazine, ACNU and vincristine) for high-grade gliomas: a prospective study.
    Ogawa K; Yoshii Y; Toita T; Saito A; Kakinohana Y; Iraha S; Sugimoto K; Tsuchida Y; Tamaki W; Adachi G; Hyodo A; Murayama S
    Anticancer Res; 2006; 26(3B):2457-62. PubMed ID: 16821632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of topotecan in combination with concurrent radiotherapy in adults with glioblastoma.
    Lesimple T; Hassel MB; Gédouin D; Seigneuret E; Carsin B; Hamlat A; Riffaud L; Simon H; Malhaire JP; Guégan Y
    J Neurooncol; 2003 Nov; 65(2):141-8. PubMed ID: 14686734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent accelerated hyperfractionated radiation therapy and carboplatin/etoposide in patients with malignant glioma: long-term results of a phase II study.
    Jeremic B; Shibamoto Y; Grujicic D; Stojanovic M; Milicic B; Nikolic N; Dagovic A; Aleksandrovic J
    J Neurooncol; 2001 Jan; 51(2):133-41. PubMed ID: 11386410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study.
    Jeremic B; Grujicic D; Antunovic V; Djuric L; Stojanovic M; Shibamoto Y
    Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1179-85. PubMed ID: 7961028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of nimustine, carboplatin, vincristine, and interferon-beta with radiotherapy for glioblastoma multiforme: experience of the Kyoto Neuro-Oncology Group.
    Aoki T; Takahashi JA; Ueba T; Oya N; Hiraoka M; Matsui K; Fukui T; Nakashima Y; Ishikawa M; Hashimoto N
    J Neurosurg; 2006 Sep; 105(3):385-91. PubMed ID: 16961130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant intraarterial chemotherapy with nimustine in the management of World Health Organization Grade IV gliomas of the brain. Experience at the Department of Neurosurgery of Düsseldorf University.
    Roosen N; Kiwit JC; Lins E; Schirmer M; Bock WJ
    Cancer; 1989 Nov; 64(10):1984-94. PubMed ID: 2553234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy with ACNU and radiation therapy in malignant glioma in cerebral hemisphere of adult].
    Miyagami M; Tsubokawa T
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1447-53. PubMed ID: 2117885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined postoperative radiotherapy and chemotherapy for malignant gliomas].
    Aida T; Sugimoto S; Tokuda K; Abe H; Ikoda T; Itoh T; Ueno K; Kashiwaba T; Kaneko S; Kawamoto T
    Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):952-9. PubMed ID: 2167916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic results of intra-arterial chemotherapy in patients with malignant glioma.
    Hirano Y; Mineura K; Mizoi K; Tomura N
    Int J Oncol; 1998 Sep; 13(3):537-42. PubMed ID: 9683790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of malignant gliomas with high-dose ACNU and autologous bone marrow transplantation].
    Nakagawa H; Murasawa A; Taki T; Nakajima S; Niiyama K; Furuta Y; Nakamura H; Shibata H; Masaoka T
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3153-7. PubMed ID: 2847660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305).
    Shibui S; Narita Y; Mizusawa J; Beppu T; Ogasawara K; Sawamura Y; Kobayashi H; Nishikawa R; Mishima K; Muragaki Y; Maruyama T; Kuratsu J; Nakamura H; Kochi M; Minamida Y; Yamaki T; Kumabe T; Tominaga T; Kayama T; Sakurada K; Nagane M; Kobayashi K; Nakamura H; Ito T; Yazaki T; Sasaki H; Tanaka K; Takahashi H; Asai A; Todo T; Wakabayashi T; Takahashi J; Takano S; Fujimaki T; Sumi M; Miyakita Y; Nakazato Y; Sato A; Fukuda H; Nomura K
    Cancer Chemother Pharmacol; 2013 Feb; 71(2):511-21. PubMed ID: 23228988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in glioblastoma multiforme patients receiving high-dose particle radiotherapy or conventional radiotherapy.
    Matsuda M; Yamamoto T; Ishikawa E; Nakai K; Zaboronok A; Takano S; Matsumura A
    Br J Radiol; 2011 Dec; 84 Spec No 1(Spec Iss 1):S54-60. PubMed ID: 21427185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of radiotherapy after hyperbaric oxygenation with multiagent chemotherapy (procarbazine, nimustine, and vincristine) for high-grade gliomas: long-term results.
    Ogawa K; Ishiuchi S; Inoue O; Yoshii Y; Saito A; Watanabe T; Iraha S; Toita T; Kakinohana Y; Ariga T; Kasuya G; Murayama S
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):732-8. PubMed ID: 21420247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors.
    Piroth MD; Gagel B; Pinkawa M; Stanzel S; Asadpour B; Eble MJ
    Strahlenther Onkol; 2007 Dec; 183(12):695-702. PubMed ID: 18040615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.